Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
34,928,326
-
Share change
-
+4,210,929
-
Total reported value
-
$207,138,467
-
Put/Call ratio
-
177%
-
Price per share
-
$5.94
-
Number of holders
-
52
-
Value change
-
+$26,188,083
-
Number of buys
-
32
-
Number of sells
-
32
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q1 2020
As of 31 Mar 2020,
Aptose Biosciences Inc. - Common Shares was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,928,326 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, Consonance Capital Management LP, Opaleye Management Inc., DRW Securities, LLC, Polar Capital LLP, Corriente Advisors, LLC, PICTET ASSET MANAGEMENT LTD, MILLENNIUM MANAGEMENT LLC, Precept Management LLC, and GOLDMAN SACHS GROUP INC.
This page lists
52
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.